Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease

Papassotiropoulos, Andreas, Lambert, Jean-Charles, Wavrant-De Vrièze, Fabienne, Wollmer, M. Axel, von der Kammer, Heinz, Streffer, Johannes R., Maddalena, Alessia, Huynh, Kim-Dung, Wolleb, Sibylle, Lütjohann, Dieter, Schneider, Brigitte, Thal, Dietmar R., Grimaldi, Luigi M.E., Tsolaki, Magdalini, Kapaki, Elisabeth, Ravid, Rivka, Konietzko, Uwe, Hegi, Thomas, Pasch, Thomas, Jung, Hans, Braak, Heiko, Amouyel, Philippe, Rogaev, Evgeny I., Hardy, John, Hock, Christoph, Nitsch, Roger M.·2005·Neurodegenerative Diseases

Abstract

Alzheimer’s disease (AD) is the most common cause of dementia. It is characterized by β-amyloid (Aβ) plaques, neurofibrillary tangles and the degeneration of specifically vulnerable brain neurons. We observed high expression of the cholesterol 25-hydroxylase (CH25H) gene in specifically vulnerable brain regions of AD patients. CH25H maps to a region within 10q23 that has been previously linked to sporadic AD. Sequencing of the 5′ region of CH25H revealed three common haplotypes, CH25H χ 2, CH25H χ 3 and CH25H χ 4; CSF levels of the cholesterol precursor lathosterol were higher in carriers of the CH25H χ 4 haplotype. In 1,282 patients with AD and 1,312 healthy control subjects from five independent populations, a common variation in the vicinity of CH25H was significantly associated with the risk for sporadic AD (p = 0.006). Quantitative neuropathology of brains from elderly non-demented subjects showed brain Aβ deposits in carriers of CH25H χ 4 and CH25H χ 3 haplotypes, whereas no Aβ deposits were present in CH25H χ 2 carriers. Together, these results are compatible with a role of CH25H χ 4 as a putative susceptibility factor for sporadic AD; they may explain part of the linkage of chromosome 10 markers with sporadic AD, and they suggest the possibility that CH25H polymorphisms are associated with different rates of brain Aβ deposition.

Overview

Integrity signals

Registry

Crossref · 10.1159/000090362

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An association of CH25H with Alzheimer's disease was first reported in a hippocampal microarray study of AD brain tissue and further suggested by an AlzGene meta-analysis for a sporadic AD population and other AD patient-based independent systematic analyses.

    “An association of CH25H with AD was first reported in a hippocampal microarray study of AD brain tissue [53] and further suggested by an AlzGene meta-analysis for a sporadic AD population [54] and other AD patient-based independent systematic analyses [55–57].”
  • CH25H is located on chromosome 10q23, a region strongly linked to AD.

    “CH25H is located on chromosome 10q23, a region strongly linked to AD [54].”
  • A significant association of rs13500 'T' allele and haplotypes in the CH25H promoter with the risk of developing AD and with different rates of Aβ/amyloid deposition was previously reported in a large scale AlzGene meta-analysis.

    “In a large scale AlzGene meta-analysis including 1282 AD patients and 1312 controls from five independent populations (French, Russian, USA, Swiss, Mediterranean), a significant association of rs13500 ‘T’ allele and haplotypes in the CH25H promoter was previously reported to be associated with the risk of developing AD and with different rates of Aβ/amyloid deposition [54].”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. 10.1016%2FS0306-4522%2802%2900180-X · DOI
  2. 10.1074%2Fjbc.273.51.34316 · DOI · Paper page
  3. 10.1126%2Fscience.290.5500.2302 · DOI
  4. 10.1093%2Fhmg%2F8.2.237 · DOI
  5. 10.1002%2Fajmg.10183 · DOI
  6. 10.1046%2Fj.1471-4159.2001.t01-1-00231.x · DOI
  7. 10.1007%2Fs00439-004-1107-9 · DOI
  8. 10.1002%2Fhumu.20012 · DOI
  9. 10.1016%2Fj.nbd.2004.09.011 · DOI
  10. 10.1001%2Farchneur.60.1.29 · DOI
  11. 10.1016%2FS0197-4580%2802%2900094-5 · DOI
  12. 10.1038%2Fsj.mp.4001296 · DOI
  13. 10.1192%2Fbjp.140.6.566 · DOI · Paper page
  14. 10.1006%2Fabio.1995.1110 · DOI
  15. 10.1054%2Fmodi.2000.19218 · DOI
  16. 10.1038%2Fsj.ejhg.5200625 · DOI
  17. 10.1074%2Fjbc.273.23.14538 · DOI
  18. 10.1093%2Fnar%2F27.10.2211 · DOI
  19. 10.1210%2Fme.15.5.812 · DOI
  20. 10.1093%2Fnar%2F23.23.4878 · DOI
  21. 10.1016%2F0039-128X%2894%2900002-T · DOI
  22. 10.1210%2Fen.140.7.3034 · DOI
  23. 10.1016%2Fj.expneurol.2003.09.004 · DOI
  24. 10.1126%2Fscience.290.5500.2303 · DOI
  25. 10.1126%2Fscience.290.5500.2304 · DOI
  26. 10.1002%2Fana.410380413 · DOI · Paper page
  27. 10.1016%2FS0196-9781%2802%2900056-6 · DOI

Cited by

Sorted by citations

Metadata

Authors
Papassotiropoulos, A., Lambert, J.-C., Wavrant-De Vrièze, F., Wollmer, M. A., von der Kammer, H., Streffer, J. R., Maddalena, A., Huynh, K.-D., Wolleb, S., Lütjohann, D., Schneider, B., Thal, D. R., Grimaldi, L. M. E., Tsolaki, M., Kapaki, E., Ravid, R., Konietzko, U., Hegi, T., Pasch, T., Jung, H., Braak, H., Amouyel, P., Rogaev, E. I., Hardy, J., Hock, C., & Nitsch, R. M.
Venue
Neurodegenerative Diseases
Publisher
S. Karger AG
Published
2005
Volume
2
Issue
5
Pages
233-241
ISSN
  • 1660-2854
  • 1660-2862
Cited by
51
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review